BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions.
Biomarin Pharmaceutical stock last closed at $97.24, up 2.05% from the previous day, and has increased 26.12% in one year. It has overperformed other stocks in the Biotechnology industry by 0.52 percentage points. Biomarin Pharmaceutical stock is currently +37.48% from its 52-week low of $70.73, and -17.43% from its 52-week high of $117.77.
At the moment, there are 186.53M shares of BMRN outstanding. The market value of BMRN is $18.14B. In the last 24 hours, 1.43M BMRN shares were traded.
You need an online brokerage account in order to access the NASDAQ market and buy BMRN stock.
We believe that eToro is the best stock brokerage. Here's why:
Get $10 towards your purchase of shares by opening an account with eToro today.
Open eToro AccountNow that you've selected your brokerage, you'll need to fill out some personal info so you are able to buy BMRN stock today.
Now that you've created your account on apps for stock market, your next step is to transfer the money for your investment:
Check out the walkthrough below if you need help transferring money into your investment account.
Once you have decided on the best place to buy Biomarin Pharmaceutical stock, it's absolutely critical to research their stock prior to investing, so you actually understand the risk as well as the upside.
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis quickly.
You can view all of the due diligence checks on BMRN's stock page.
You can use many financial metrics, analyses, models, and charts to gauge BMRN's intrinsic value.
Using relative valuations ratios:
You can access more valuation analysis on BMRN's stock here.
Out of 14 Wall Street analysts who give forecasts on BMRN, the consensus analyst rating on Biomarin Pharmaceutical is a Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
William Pickering, a bottom 40% analyst from Bernstein initiates coverage on BMRN with a sell rating and announces their BMRN price target of $81.00, on Mar 21, 2023.
Kostas Biliouris, a bottom 11% analyst from BMO Capital maintains BMRN with a hold rating and lowers their BMRN price target from $107.00 to $102.00, on Mar 7, 2023.
Debjit Chattopadhyay, a bottom 17% analyst from Guggenheim reiterates BMRN with a strong buy rating and maintains their BMRN price target from $125.00 to $125.00, on Feb 28, 2023.
Paul Matteis, a bottom 10% analyst from Stifel Nicolaus maintains BMRN with a strong buy rating and raises their BMRN price target from $114.00 to $118.00, on Feb 28, 2023.
Andreas Argyrides, a bottom 15% analyst from Wedbush maintains BMRN with a hold rating and lowers their BMRN price target from $83.00 to $74.00, on Feb 28, 2023.
You can dive deeper into what analysts are forecasting on the Biomarin Pharmaceutical stock forecast page.
Last year, BMRN earnings were $141.56M. In the last 2 year, BMRN's earnings have grown by -59.87% per year. This was slower than the Biotechnology industry average of 64.65%.
Last year, BMRN revenue was $2.10B. Over the past 5 year, BMRN's revenue has increased by 9.8% per year. This was slower than the Biotechnology industry average of 41.53%.
Find out more about BMRN's earnings and revenue performance here.
Over the past 12 months, insiders at BMRN have sold more shares than they have bought.
Jeffrey Robert Ajer, EVP Chief Commercial Officer of BMRN, was the latest BMRN insider to sell. They sold $1,915,839.10 worth of BMRN shares on Mar 16, 2023.
Get more info about who owns BMRN stock here.
No, Biomarin Pharmaceutical doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
There are two primary order types:
Hit the Open Trade button and your broker will execute the order.
If you need more info about investing in stocks on eToro, click the how to video below:
Now that you own some BMRN stock, you'll want to stay up-to-date on your stock purchase.
Start a watchlist to see the latest developments about your BMRN stock.
To reiterate, here are the 6 steps to buy Biomarin Pharmaceutical stock:
If you are looking for a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to watch your new investment in Biomarin Pharmaceutical, click the button below.